nach oben

Rheumatology International

Erschienen in:

09.11.2017 | Systematic Review

Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review

verfasst von: Telma Thrastardottir, Thorvardur Jon Love

Erschienen in: Rheumatology International | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Psoriasis and psoriatic arthritis (PsA) are related inflammatory diseases with some shared genetic and environmental risk factors. It has been suggested that environmental factors, including infections, can trigger the development of PsA among psoriasis patients. The aim of this review was to systematically examine available data evaluating the effect of infections on the risk of developing PsA. A systematic search of the Cochrane Library, PubMed, Scopus, and Web of Science was conducted on March 16 2017, in accordance with the PRISMA statement. The following search terms were used along with “psoriatic arthritis”: “infections”, “risk”, “bacteria”, and “virus”. Abstracts were reviewed and publications meeting the following criteria included: (1) Observational studies on psoriasis and PsA patients, including case–control, cohort, or ecologic studies and (2) presenting original data on the association between infections and PsA. The protocol for this systematic review was registered on PROSPERO (ID: 79432). Twenty-seven original studies presenting data on infections among PsA patients were included. Eight studies showed a statistically significant association between infections and PsA. In addition, seven studies reported mixed result with some statistically significant associations and five studies did not find statistically significant associations. This included studies of bacterial as well as viral pathogens and those of infections in general. The remaining seven studies lacked data to determine statistical significance. Out of all included studies, the total number of included patients was 933 PsA patients and 1611 controls. While the studies summarized did not all provide evidence supporting an association between infections and PsA certain trends emerged. The available data are inconsistent and further studies are needed to verify or refute this purported association. In particular, laryngeal infections and infections involving streptococci should be studied more carefully.

Langley RG, Krueger GG, Griffiths CE (2005) Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 64(Suppl 2):ii18–ii23. https://doi.org/10.1136/ard.2004.033217 (discussion ii24-15) CrossRef

Gladman DD, Brockbank J (2000) Psoriatic arthritis. Expert Opin Investig Drugs 9(7):1511–1522. https://doi.org/10.1517/13543784.9.7.1511 CrossRefPubMed

Mease PJ, Menter MA (2006) Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective. J Am Acad Dermatol 54(4):685–704. https://doi.org/10.1016/j.jaad.2005.10.008 CrossRefPubMed

Karason A, Love TJ, Gudbjornsson B (2009) A strong heritability of psoriatic arthritis over four generations—the Reykjavik Psoriatic Arthritis Study. Rheumatology (Oxford) 48(11):1424–1428. https://doi.org/10.1093/rheumatology/kep243 CrossRef

Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD (2012) Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis 71(1):50–55. https://doi.org/10.1136/ard.2011.155044 CrossRefPubMed

Bruce IN, Silman AJ (2001) The aetiology of psoriatic arthritis. Rheumatology (Oxford) 40(4):363–366CrossRef

Setty AR, Curhan G, Choi HK (2007) Smoking and the risk of psoriasis in women: Nurses’ Health Study II. Am J Med 120(11):953–959. https://doi.org/10.1016/j.amjmed.2007.06.020 CrossRefPubMedPubMedCentral

Raychaudhuri SP, Farber EM (2001) The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 15(1):16–17CrossRef

Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, Kristinsson KG, Valdimarsson H (2003) Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 149(3):530–534CrossRef

10.

Gudjonsson JE, Karason A, Runarsdottir EH, Antonsdottir AA, Hauksson VB, Jonsson HH, Gulcher J, Stefansson K, Valdimarsson H (2006) Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients—an analysis of 1019 HLA-C- and HLA-B-typed patients. J Invest Dermatol 126(4):740–745. https://doi.org/10.1038/sj.jid.5700118 CrossRefPubMed

11.

Reveille JD, Williams FM (2006) Rheumatologic complications of HIV infection. Best Pract Res Clin Rheumatol 20(6):1159–1179. https://doi.org/10.1016/j.berh.2006.08.015 CrossRefPubMed

12.

Pattison E, Harrison BJ, Griffiths CEM, Silman AJ, Bruce IN (2008) Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 67(5):672–676. https://doi.org/10.1136/ard.2007.073932 CrossRefPubMed

13.

Thorarensen SM, Lu N, Ogdie A, Gelfand JM, Choi HK, Love TJ (2017) Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis. Ann Rheum Dis 76(3):521–525. https://doi.org/10.1136/annrheumdis-2016-209334 CrossRefPubMed

14.

Love TJ, Zhu YY, Zhang YQ, Wall-Burns L, Ogdie A, Gelfand JM, Choi HK (2012) Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 71(8):1273–1277. https://doi.org/10.1136/annrheumdis-2012-201299 CrossRefPubMedPubMedCentral

15.

Eder L, Law T, Chandran V, Shanmugarajah S, Shen H, Rosen CF, Cook RJ, Gladman DD (2011) Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken) 63(8):1091–1097. https://doi.org/10.1002/acr.20496 CrossRef

16.

Li W, Han J, Qureshi AA (2012) Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 71(8):1267–1272. https://doi.org/10.1136/annrheumdis-2011-201273 CrossRefPubMedPubMedCentral

17.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1. https://doi.org/10.1186/2046-4053-4-1 CrossRefPubMedPubMedCentral

18.

Muto M, Date Y, Ichimiya M, Moriwaki Y, Mori K, Kamikawaji N, Kimura A, Sasazuki T, Asagami C (1996) Significance of antibodies to streptococcal M protein in psoriatic arthritis and their association with HLA-A*0207. Tissue Antigens 48(6):645–650. https://doi.org/10.1111/j.1399-0039.1996.tb02687.x CrossRefPubMed

19.

Rantakokko K, Rimpilainen M, Uksila J, Jansen C, Luukkainen R, Toivanen P (1997) Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. Clin Exp Rheumatol 15(4):399–404PubMed

20.

Vasey FB, Deitz C, Fenske NA, Germain BF, Espinoza LR (1982) Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol 9(5):719–722PubMed

21.

Wang QM, Vasey FB, Mahfood JP, Valeriano J, Kanik KS, Anderson BE, Bridgeford PH (1999) V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis. Arthritis Rheum 42(10):2055–2059. https://doi.org/10.1002/1529-0131(199910)42:10<2055::aid-anr5>3.0.co;2-a CrossRef

22.

Grinlinton FM, Skinner MA, Birchall NM, Tan PL (1993) Gamma delta + T cells from patients with psoriatic and rheumatoid arthritis respond to streptococcal antigen. J Rheumatol 20(6):982–987PubMed

23.

Thumboo J, Uramoto K, Shbeeb MI, O’Fallon WM, Crowson CS, Gibson LE, Michet CJ, Gabriel SE (2002) Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol 29(4):757–762PubMed

24.

Rahman MU, Ahmed S, Schumacher HR, Zeiger AR (1990) High levels of antipeptidoglycan antibodies in psoriatic and other seronegative arthritides. J Rheumatol 17(5):621–625PubMed

25.

Yamamoto T, Katayama I, Nishioka K (1999) Peripheral blood mononuclear cell proliferative response against staphylococcal superantigens in patients with psoriasis arthropathy. Eur J Dermatol 9(1):17–21PubMed

26.

Lapadula G, Iannone F, Covelli M, Numo R, Pipitone V (1992) Antienterobacteria 14 antibodies in psoriatic-arthritis. Clin Exp Rheumatol 10 (5):461–466PubMed

27.

Silveira LH, Gutierrez F, Scopelitis E, Cuellar ML, Citera G, Espinoza LR (1993) Chlamydia-induced reactive arthritis Rheumatic. Dis Clin N Am 19(2):351–362

28.

Lapadula G, Covelli M, Numo R (1988) Antibacterial antibody pattern in seronegative spondyloarthropathies (SNSA). Clin Exp Rheumatol 6(4):385–390PubMed

29.

Stinco G, Fabris M, Pasini E, Pontarini E, Patriarca MM, Piccirillo F, De Vita S, Dolcetti R (2012) Detection of DNA of Chlamydophila psittaci in subjects with psoriasis: a casual or a causal link? Br J Dermatol 167(4):926–928. https://doi.org/10.1111/j.1365-2133.2012.11043.x CrossRefPubMed

30.

Fabris M, De Vita S, Pasini E, Quartuccio L, Pontarini E, Lombardi S, Fabro C, Sarzi-Puttini P, Pellerito R, Benucci M, Morassi P, Biasi D, Curcio F, Dolcetti R (2011) Chlamydophila psittaci subclinical infection in chronic polyarthritis. Clin Exp Rheumatol 29(6):977–982PubMed

31.

Trull AK, Ebringer R, Panayi GS, Colthorpe D, James DC, Ebringer A (1983) IgA antibodies to Klebsiella pneumoniae in ankylosing spondylitis. Scand J Rheumatol 12(3):249–253CrossRef

32.

Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, Huttenhower C, Littman DR (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife. https://doi.org/10.7554/eLife.01202.001 CrossRefPubMedPubMedCentral

33.

Moen K, Brun JG, Valen M, Skartveit L, Eribe EKR, Olsen I, Jonsson R (2006) Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 24(6):656–663PubMed

34.

Eder L, Haddad A, Rosen CF, Lee KA, Chandran V, Cook R, Gladman DD (2016) The incidence and risk factors for psoriatic arthritis in patients with psoriasis a prospective cohort study. Arthritis Rheumatol 68(4):915–923. https://doi.org/10.1002/art.39494 CrossRefPubMed

35.

Louthrenoo W (1997) Musculoskeletal Manifestations of HIV Infection in Thailand: An Analysis of 100 Cases. J Clin Rheumatol 3(5):258–268CrossRef

36.

Njobvu P, McGill P (2000) Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol 27(7):1699–1702PubMed

37.

Njobvu P, McGill P, Kerr H, Jellis J, Pobee J (1998) Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 25(8):1553–1559PubMed

38.

Palazzi C, Olivieri I, D’Amico E, D’Agostino L, Nicolucci A, Pennese E, Petricca A (2005) Hepatitis C virus infection in psoriatic arthritis. Arthritis Rheum-Arthritis Care Res 53(2):223–225. https://doi.org/10.1002/art.21079 CrossRef

39.

Taglione E, Vatteroni ML, Martini P, Galluzzo E, Lombardini F, Delle Sedie A, Bendinelli M, Pasero G, Bencivelli W, Riente L (1999) Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis. J Rheumatol 26(2):370–372PubMed

40.

Sagnelli E, Gaeta GB, Felaco FM, Stroffolini T, Conti S, Glielmo A, Piccinino F, Giusti G (1997) Hepatitis C virus infection in households of anti-HCV chronic carriers in Italy: a multicentre case-control study. Infection 25(6):346–349CrossRef

41.

Mehraein Y, Lennerz C, Ehlhardt S, Remberger K, Jak A, Zang KD (2004) Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization. Mod Pathol 17(7):781–789. https://doi.org/10.1038/modpathol.3800119 CrossRefPubMed

42.

Mehraein Y, Lennerz C, Ehlhardt S, Venzke T, Ojak A, Remberger K, Zang KD (2003) Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis. Mod Pathol 16(8):811–817. https://doi.org/10.1097/01.mp.0000083145.68333.9b CrossRefPubMed

43.

Brzewski PŁ, Spałkowska M, Podbielska M, Chmielewska J, Wołek M, Malec K, Wojas-Pelc A (2013) The role of focal infections in the pathogenesis of psoriasis and chronic urticaria. Postepy Dermatologii i Alergologii 30(2):77–84. https://doi.org/10.5114/pdia.2013.34155 CrossRefPubMedPubMedCentral

44.

Schaeverbeke T, Renaudin H, Clerc M, Lequen L, Vernhes JP, De Barbeyrac B, Bannwarth B, Bebear C, Dehais J (1997) Systematic detection of mycoplasmas by culture and polymerase chain reaction (PCR) procedures in 209 synovial fluid samples. Br J Rheumatol 36(3):310–314CrossRef

45.

Johnson S, Sidebottom D, Bruckner F, Collins D (2000) Identification of Mycoplasma fermentans in synovial fluid samples from arthritis patients with inflammatory disease. J Clin Microbiol 38(1):90–93PubMedPubMedCentral

46.

Punzi L, Pianon M, Pozzuoli A, Oliviero F, Salvati GP, Gambari PF (2000) Psoriatic arthritis exacerbated by Salmonella infection. Clin Rheumatol 19(2):167–168CrossRef

47.

Skory L, Shearn MA (1979) Psoriatic arthritis induced by varicella. West J Med 131(5):440–441PubMedPubMedCentral

48.

Thorleifsdottir RH, Eysteinsdottir JH, Olafsson JH, Sigurdsson MI, Johnston A, Valdimarsson H, Sigurgeirsson B (2016) Throat infections are associated with exacerbation in a substantial proportion of patients with chronic plaque psoriasis. Acta Derm Venereol 96(6):788–791. https://doi.org/10.2340/00015555-2408 CrossRefPubMedPubMedCentral

49.

Thorleifsdottir RH, Sigurdardottir SL, Sigurgeirsson B, Olafsson JH, Sigurdsson MI, Petersen H, Gudjonsson JE, Johnston A, Valdimarsson H (2017) Patient-reported outcomes and clinical response in patients with moderate-to-severe plaque psoriasis treated with tonsillectomy: a randomized controlled Trial. Acta Derm Venereol 97(3):340–345. https://doi.org/10.2340/00015555-2562 CrossRefPubMed

50.

Carrasco S, Neves FS, Fonseca MH, Goncalves CR, Saad CG, Sampaio-Barros PD, Goldenstein-Schainberg C (2011) Toll-like receptor (TLR) 2 is upregulated on peripheral blood monocytes of patients with psoriatic arthritis: a role for a gram-positive inflammatory trigger? Clin Exp Rheumatol 29(6):958–962PubMed

51.

Yen YF, Jen IA, Chen M, Lan YC, Lee CY, Chuang PH, Lee Y, Arthur Chen YM (2017) HIV Infection Increases the Risk of Incident Psoriasis: A Nationwide Population-Based Cohort Study in Taiwan. J Acquir Immune Defic Syndr 75(5):493–499. https://doi.org/10.1097/qai.0000000000001431 CrossRefPubMed

52.

Morar N, Willis-Owen SA, Maurer T, Bunker CB (2010) HIV-associated psoriasis: pathogenesis, clinical features, and management. Lancet Infect Dis 10(7):470–478. https://doi.org/10.1016/s1473-3099(10)70101-8 CrossRefPubMed

53.

Menon B, Gullick NJ, Walter GJ, Rajasekhar M, Garrood T, Evans HG, Taams LS, Kirkham BW (2014) Interleukin-17 + CD8 + T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheumatol 66(5):1272–1281. https://doi.org/10.1002/art.38376 CrossRefPubMedPubMedCentral

Titel: Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review
verfasst von: Telma Thrastardottir
Thorvardur Jon Love
Publikationsdatum: 09.11.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 8/2018
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-017-3873-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2018

A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q

Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis

2017 update of the Turkish League Against Rheumatism (TLAR) evidence-based recommendations for the management of knee osteoarthritis

Reduced anterior cingulate grey matter volume in painful hand osteoarthritis

Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases